158 related articles for article (PubMed ID: 23794209)
21. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
23. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.
Chung S; Furihata M; Tamura K; Uemura M; Daigo Y; Nasu Y; Miki T; Shuin T; Fujioka T; Nakamura Y; Nakagawa H
Oncogene; 2009 Aug; 28(32):2849-59. PubMed ID: 19483721
[TBL] [Abstract][Full Text] [Related]
24. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
25. Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.
Zolochevska O; Figueiredo ML
Prostate; 2009 Oct; 69(14):1586-97. PubMed ID: 19585490
[TBL] [Abstract][Full Text] [Related]
26. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways.
Ma W; Na M; Tang C; Wang H; Lin Z
Mol Med Rep; 2015 Jul; 12(1):1050-8. PubMed ID: 25777142
[TBL] [Abstract][Full Text] [Related]
28. Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.
Yamasaki M; Nomura T; Sato F; Mimata H
Oncol Rep; 2007 Nov; 18(5):1145-53. PubMed ID: 17914565
[TBL] [Abstract][Full Text] [Related]
29. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
[TBL] [Abstract][Full Text] [Related]
30. Maspin is up-regulated in premalignant prostate epithelia.
Pierson CR; McGowen R; Grignon D; Sakr W; Dey J; Sheng S
Prostate; 2002 Dec; 53(4):255-62. PubMed ID: 12430137
[TBL] [Abstract][Full Text] [Related]
31. Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1).
Liu R; Li J; Teng Z; Zhang Z; Xu Y
PLoS One; 2013; 8(7):e68982. PubMed ID: 23874837
[TBL] [Abstract][Full Text] [Related]
32. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
[TBL] [Abstract][Full Text] [Related]
33. N-myc downstream regulated gene 1 acts as a tumor suppressor in ovarian cancer.
Wang B; Li J; Ye Z; Li Z; Wu X
Oncol Rep; 2014 May; 31(5):2279-85. PubMed ID: 24626771
[TBL] [Abstract][Full Text] [Related]
34. [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro].
Ma L; Shen YY; Zhou P; Zhou J; Guo F
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):165-8. PubMed ID: 22780967
[TBL] [Abstract][Full Text] [Related]
35. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
36. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms by which interleukin-6 regulates prostate-specific antigen gene expression in prostate LNCaP carcinoma cells.
Tsui KH; Lin YF; Chen YH; Chang PL; Juang HH
J Androl; 2011; 32(4):383-93. PubMed ID: 21051589
[TBL] [Abstract][Full Text] [Related]
38. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.
Miyazaki H; Watabe T; Kitamura T; Miyazono K
Oncogene; 2004 Dec; 23(58):9326-35. PubMed ID: 15531927
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.
Shima T; Mizokami A; Miyagi T; Kawai K; Izumi K; Kumaki M; Ofude M; Zhang J; Keller ET; Namiki M
Prostate; 2012 Dec; 72(16):1789-801. PubMed ID: 22549914
[TBL] [Abstract][Full Text] [Related]
40. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
Tsui KH; Lin YH; Chung LC; Chuang ST; Feng TH; Chiang KC; Chang PL; Yeh CJ; Juang HH
Cancer Lett; 2016 May; 375(1):142-151. PubMed ID: 26965996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
